Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oramed Pharma (ORMP)

Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 108,261
  • Shares Outstanding, K 39,802
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,060 K
  • EBIT $ -14 M
  • EBITDA $ -13 M
  • 60-Month Beta 1.18
  • Price/Sales 57.66
  • Price/Cash Flow N/A
  • Price/Book 0.55

Options Overview Details

View History
  • Implied Volatility 543.82% (+81.73%)
  • Historical Volatility 50.95%
  • IV Percentile 92%
  • IV Rank 38.43%
  • IV High 1,355.25% on 11/14/25
  • IV Low 37.39% on 11/05/25
  • Expected Move (DTE 14) 0.38 (14.22%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 66
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 710
  • Open Int (30-Day) 1,103
  • Expected Range 2.31 to 3.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year 0.01
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.09 +28.71%
on 11/07/25
2.99 -10.03%
on 11/25/25
+0.45 (+20.09%)
since 11/05/25
3-Month
2.09 +28.71%
on 11/07/25
2.99 -10.03%
on 11/25/25
+0.46 (+20.63%)
since 09/05/25
52-Week
1.82 +47.80%
on 04/09/25
3.09 -12.94%
on 02/11/25
+0.18 (+7.17%)
since 12/05/24

Most Recent Stories

More News
Oramed Reports Fiscal Third Quarter 2025 Financial Results

Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Million

ORMP : 2.69 (-1.10%)
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the "Company") announced today that it has unanimously adopted a Rights Agreement, dated November 17,...

ORMP : 2.69 (-1.10%)
Oramed: Q3 Earnings Snapshot

Oramed: Q3 Earnings Snapshot

ORMP : 2.69 (-1.10%)
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives

NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed" or the "Company" or "we"), a clinical-stage pharmaceutical company, today issued a Letter...

ORMP : 2.69 (-1.10%)
Oramed Pharm Completes Warrant Repurchase Agreement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Oramed Pharm...

ORMP : 2.69 (-1.10%)
Oramed: Q2 Earnings Snapshot

Oramed: Q2 Earnings Snapshot

ORMP : 2.69 (-1.10%)
Oramed: Q1 Earnings Snapshot

Oramed: Q1 Earnings Snapshot

ORMP : 2.69 (-1.10%)
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

ORMP : 2.69 (-1.10%)
DRTS : 3.89 (-4.19%)
DRTSW : 0.3380 (+5.63%)
Oramed: Q2 Earnings Snapshot

Oramed: Q2 Earnings Snapshot

ORMP : 2.69 (-1.10%)
Oramed: Q1 Earnings Snapshot

Oramed: Q1 Earnings Snapshot

ORMP : 2.69 (-1.10%)

Business Summary

Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 2.82
2nd Resistance Point 2.78
1st Resistance Point 2.74
Last Price 2.69
1st Support Level 2.66
2nd Support Level 2.62
3rd Support Level 2.58

See More

52-Week High 3.09
Last Price 2.69
Fibonacci 61.8% 2.60
Fibonacci 50% 2.45
Fibonacci 38.2% 2.31
52-Week Low 1.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar